FTO decreases m6A levels on the AML-associated genes ASB2 and RARA, thus resulting in inhibition of all-trans-retinoic acid-induced AML cell differentiation and enhanced leukemogenesis40. The gene discussed is FTO; the disease is acute myeloid leukemia.